Markets:

Overview

News

Currencies

International

Treasuries

Rhythm Pharmaceuticals, Inc. - Common Stock (NQ:RYTM)

107.02 +0.26 (+0.24%)

Streaming Delayed Price Updated: 11:44 AM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Rhythm Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

The Great Divergence: Why Big Tech Holds the Line While Logistics and Biotech Face a 2026 Reckoning

December 30, 2025

As the curtain closes on 2025, the financial landscape presents a tale of two markets. While the S&P 500 (NYSEARCA: SPY) hovers near the historic 7,000-point milestone, fueled by a 19% year-to-date...

Via MarketMinute

Rhythm Pharmaceuticals Faces Gravity: FDA Delays and Valuation Pressures Cool 2025’s Biotech Darling

December 30, 2025

As the final trading days of 2025 wind down, Rhythm Pharmaceuticals (Nasdaq: RYTM) finds itself at a critical crossroads. After a meteoric rise that saw the stock gain over 100% through the first three...

Via MarketMinute

Topics ETFs Economy World Trade

Rhythm Pharmaceuticals Stock Rises After Positive Study Data For Setmelanotide In Treating Genetic Disorder ↗

December 11, 2025

The company was studying the therapy in Prader-Willi Syndrome, a rare genetic disorder requiring lifelong management.

Via Stocktwits

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Rhythm Pharmaceuticals's Earnings: A Preview ↗

November 03, 2025

Via Benzinga

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

The market is filled with gapping stocks in Thursday's session. ↗

December 11, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Stay updated with the stocks that are on the move in today's after-hours session. ↗

December 10, 2025

Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

These stocks are moving in today's after hours session ↗

November 11, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Rythm Pharmaceuticals' (RYTM) Chief Technical Officer Sells 9,748 Shares for $1.1 Million ↗

November 08, 2025

Rythm Pharmaceuticals' (RYTM) Chief Technical Officer Sells 9,748 Shares for $1.1 Million

Via The Motley Fool

Topics Regulatory Compliance

Rhythm Pharmaceuticals (NASDAQ:RYTM) Reports Mixed Q3 2025 Results ↗

November 04, 2025

Rhythm Pharmaceuticals posts mixed Q3 2025 results, missing revenue estimates. Despite the loss, the company highlights strong drug growth and key regulatory milestones for its obesity treatments.

Via Chartmill

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

October 27, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

2 Under-the-Radar Stocks That Could Soar ↗

September 21, 2025

They could ride the wave of the hottest therapeutic area in the industry.

Via The Motley Fool

Peering Into Rhythm Pharmaceuticals's Recent Short Interest ↗

September 11, 2025

Via Benzinga

12 Analysts Have This To Say About Rhythm Pharmaceuticals ↗

August 06, 2025

Via Benzinga

Rhythm (RYTM) Q2 Revenue Jumps 67% ↗

August 05, 2025

Via The Motley Fool

Topics Intellectual Property

Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider Losses ↗

August 05, 2025

Rhythm Pharmaceuticals Q2 2025 results show revenue beat but EPS miss, causing a 5.7% pre-market drop. Regulatory progress for setmelanotide remains on track.

Via Chartmill

Should You Invest in This Under-the-Radar Weight Loss Stock? ↗

July 21, 2025

Via The Motley Fool

A Glimpse Into The Expert Outlook On Rhythm Pharmaceuticals Through 10 Analysts ↗

July 18, 2025

Via Benzinga

Rhythm Pharmaceuticals CFO Sells 42,120 Shares ↗

July 18, 2025

Via The Motley Fool

Topics Regulatory Compliance

Rhythm Pharma Gets Price-Target Bump Ups To $129 After Oral Obesity Drug Impresses In Phase 2; Retail Appetite Swells ↗

July 10, 2025

Analysts from Wells Fargo, Stifel, and others raised their targets following the release of strong BMI reduction data for bivamelagon.

Via Stocktwits

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

July 09, 2025

Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Rhythm Pharma's Oral Drug For Rare Obesity Shows Promise ↗

July 09, 2025

Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 with regulators.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 09, 2025

Via Benzinga

These stocks are moving in today's session ↗

July 09, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Rhythm Pharma Shares Soar After Experimental Drug Yields Weight Reduction In Brain-Damage Related Obesity ↗

July 09, 2025

Rhythm now plans to seek input from U.S. and EU regulatory authorities on a late-stage trial design to advance Bivamelagon in acquired hypothalamic obesity.

Via Stocktwits

Topics Government

Rhythm Pharma Surges To Record High On 'Impressive' Results In Obesity ↗

July 09, 2025

Rhythm Pharmaceuticals shares surged to a record high Wednesday on promising results for a drug that could treat obesity.

Via Investor's Business Daily

Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday ↗

July 09, 2025

Via Benzinga

Which stocks are gapping on Wednesday? ↗

July 09, 2025

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

July 08, 2025

As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Rhythm Pharmaceuticals, Inc. - Common Stock (NQ:RYTM)

Headline News about Rhythm Pharmaceuticals, Inc. - Common Stock

Resources